Related Experiment Video
Updated: Jul 17, 2025

Rapid Isolation of Dorsal Root Ganglion Macrophages
Published on: September 7, 2019
[Neuropathic pain decoded by microglial heterogeneity]
1Department of Molecular and System Pharmacology, Graduate School of Pharmaceutical Sciences, Kyushu University.
Abstract:
Lesion or diseases affecting the somatosensory system causes neuropathic pain, a debilitating chronic pain condition. Previous studies using its experimental models have demonstrated the critical contribution of microglia to the development of neuropathic pain. Upon sensing nerve damage, spinal cord microglia alter their morphology, gene expression and function, which lead to an increase in the excitability of pain-transmission neural pathway, causing the pain onset. Recently, newly identified CD11c-positive microglia as a subset that increases during the remission phase of neuropathic pain has been shown to be required for spontaneous remission of neuropathic pain and to play an important role in maintaining the remission state. Thus, these findings suggest that the functions and roles of microglia under neuropathic pain conditions are not one-dimensional but change during the onset, maintenance, and remission phases, and they also provide a clue to establish a new strategy to decipher neuropathic pain and other neurological diseases from the heterogeneity of microglia.
Insights
Microglia in the spinal cord play dynamic roles in neuropathic pain. Specific CD11c-positive microglia are crucial for pain remission, highlighting cellular heterogeneity in neurological disease.
Area of Science:
- Neuroscience
- Immunology
- Pain Research
Context:
- Neuropathic pain, a chronic pain condition, arises from damage to the somatosensory system.
- Spinal cord microglia are known to contribute to neuropathic pain onset and maintenance.
- The heterogeneity of microglial function across different pain phases is increasingly recognized.
Purpose:
- To investigate the dynamic roles of microglia in the onset, maintenance, and remission phases of neuropathic pain.
- To characterize the function of CD11c-positive microglia during neuropathic pain remission.
Summary:
- Microglia in the spinal cord undergo significant changes in morphology, gene expression, and function following nerve damage, contributing to neuropathic pain.
- A distinct subset, CD11c-positive microglia, emerges during the remission phase and is essential for spontaneous pain remission and maintaining the pain-free state.
- These findings reveal that microglial roles in neuropathic pain are phase-dependent and not monolithic.
Impact:
- Suggests that targeting specific microglial subsets could offer novel therapeutic strategies for neuropathic pain.
- Highlights the importance of understanding microglial heterogeneity for deciphering complex neurological diseases.
- Provides a foundation for developing new approaches to treat chronic pain and related neurological disorders.
Related Concept Videos
Nociception
Local Anesthetics: Differential Sensitivity of Nerve Fibers
Analgesia and Pain Management
Pain

